A settlement was reached with the defendants in the lawsuit filed on behalf of certain investors of IsoRay Inc (NYSEMKT:ISR) over alleged securities laws violations and a deadline to submit the settlement claim is upcoming on January 3, 2017 and NYSEMKT:ISR investors should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/08/2016 -- A deadline is coming up on January 3, 2017 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of IsoRay Inc (NYSEMKT:ISR) between May 20, 2015 and May 21, 2015.
Investors who purchased a significant amount of shares of IsoRay Inc (NYSEMKT:ISR) between May 20, 2015 and May 21, 2015, have certain options and should contact the Shareholders Foundation by email at email@example.com or call 858-779-1554.
The settlement proof of claim form or detailed settlement notice for the settlement in the IsoRay Inc (NYSEMKT:ISR) Investor Securities Class Action Lawsuit can be downloaded at: http://shareholdersfoundation.com/case/isoray-inc-nysemkt-isr-investor-securities-class-action-lawsuit-05222015
In order to submit a claim an investor has to submit the claim proof to the class action claim administrator in a timely manner. The deadline to submit the proof with the class administrator is January 3, 2017. The class action administrator for this case is Strategic Claims Services.
The lawsuit was originally filed in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by IsoRay Inc in connection with certain allegedly false and misleading statements made between May 20, 2015 and May 21, 2015.
According to the complaint the plaintiff alleges on behalf of purchasers of IsoRay Inc (NYSEMKT:ISR) common shares between May 20, 2015 and May 21, 2015, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that Defendants allegedly made false and/or misleading statements regarding IsoRay Inc's Celsium-131 isotope seeds and mesh for the treatment of non-small cell lung cancers and that when the true details entered the market, shares of IsoRay Inc (NYSEMKT:ISR) fell $1.10 per share or over 35% to close at $2.02 per share on May 21, 2015, damaging investors.
Those who purchased shares of IsoRay Inc (NYSEMKT:ISR) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego